Program Goals

The purpose of this activity is to educate participants on HIV-1 genetic diversity and its implications for diagnostic testing/monitoring and clinical care.

Target Audience

Infectious Disease physicians, virologists, HIV specialists, clinical laboratory and other healthcare professionals interested in the management of HIV.

Educational Objectives

Upon completion of this activity, participants should be able to:

• Describe the genetic diversity characteristic of HIV-1.
• Review the origins of HIV-1 genetic diversity.
• Evaluate the implications of HIV-1 diversity on diagnostic and patient monitoring assays
• Explain the potential clinical impact of HIV-1 diversity.
• Summarize a case study illustrating the clinical impact of HIV-1 diversity.

Faculty

John Hackett Jr., Ph.D.

Hector Bolivar, MD

P.A.C.E.^® (Professional Acknowledgement for Continuing Education)
Webcast participants can earn 1.5 contact hours of P.A.C.E.^® approved continuing education.
ASCLS P.A.C.E.^®, 6701 Democracy Blvd., Suite 300, Bethesda, MD 20817-1574
*This program is approved for continuing education for NCA, ASCP BOR, and all state licensing bodies including CA and FL.

Credit Designation — Lab Professional, P.A.C.E.^®

The American Society for Clinical Laboratory Science Professional Acknowledgment for Continuing Education (P.A.C.E.®) Program will provide 1.5 contact hour of credit.

Commercial Support Statement

This activity is supported by an educational grant from Abbott Molecular.

Disclosure of Conflicts of Interests

Instructors, planners, managers and other individuals who are in a position to control the content of this activity are required to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations. In this activity, the faculty discloses that they will not discuss any unlabeled use of drugs, devices, or procedures nor investigational products or procedures.

Faculty Disclosure Summary

*Disclosure of faculty and commercial relationships, as well as the discussion of unlabeled or unapproved use of any drug, device, or procedure by the faculty, are made known below.

Name	Type	Commercial Supporter
John Hackett Jr., Ph.D.	N.A.	N.A.
Hector Bolivar, MD	N.A.	N.A.

The American Society for Clinical Laboratory Science Disclosure Summary

Employees of The American Society for Clinical Laboratory Science, the accredited P.A.C.E.® provider for this activity, have disclosed that they have no significant financial relationships.

Dane Garvin Ltd. Disclosure Summary

Employees of Dane Garvin Ltd., the joint sponsor for this activity, have disclosed they have no significant financial relationships.

Policy on Privacy and Confidentiality

Dane Garvin Ltd. protects the privacy of personal and other information regarding participants, educational partners, and joint sponsors. Dane Garvin Ltd. and our joint sponsors will not release personally identifiable information to a third party without the individual’s consent, except such information as is required for reporting purposes to the appropriate accrediting agency.

Dane Garvin, Ltd. maintains physical, electronic and procedural safeguards that comply with federal regulations to guard your nonpublic personal information.

How to Obtain P.A.C.E.^® Credit

Viewers are expected to complete viewing the archive program before attempting to submit contact information and the session evaluation. Successful completion will lead to the issuance of a certificate for 1.5 contact hour of P.A.C.E.^® approved continuing education. To receive credit, the course must be completed before July 11, 2009.

If you attended the live presentation on June 5, 2008, and have already received P.A.C.E.^® credit for this program, you are not eligible for additional credit.

Participation in this activity should be completed in approximately 1.5 hours. Please follow these steps in order to receive P.A.C.E. ® credit for viewing the webcast:

Read all of the information above.

• View the complete archive webcast program.
• Follow the instructions provided to apply for P.A.C.E.^® credit.
• Complete the online registration (registration is free).
• Complete the online test and/or evaluation. Participants must receive a test score of at least 75% and answer all evaluation questions to receive a certificate.
• After successfully completing the online test and/or evaluation, your application will be processed by the CE provider and your certificate will be sent to you via email. Please allow 3-4 weeks for this process.

Should you have any P.A.C.E.® questions regarding this activity, please contact:
ASCLS P.A.C.E.®
6701 Democracy Blvd., Suite 300
Bethesda, MD 20817-1574
Ph: 301-657-2768
Fx: 301-657-2909
http://www.ascls.org/

For technical difficulties, please consult our Technical Instructions.

Archive Webcast Release Date: July 11, 2008
Archive Webcast Expiration Date: July 11, 2009

Click here to view the web conference

Medium Used

This program has been made available as an Internet online webcast.
"Beyond B: The Changing HIV-1 Virus and its Implications for Diagnostics and Patient Management"

Legal Disclaimer

The opinions expressed in this educational activity are those of the faculty and do not reflect the views of The American Society for Clinical Laboratory Science and/or Dane Garvin, Ltd. This educational activity may discuss off-label and/or investigational uses and dosages for therapeutic products/procedures that have not been approved by the United States Food and Drug Administration (FDA). The American Society for Clinical Laboratory Science and Dane Garvin, Ltd. do not recommend the use of any product/procedure outside of the labeled indications. A qualified health care professional should be consulted before using any therapeutic product/procedure discussed. All readers and continuing education participants should verify all information and data before treating patients or employing any therapies described in this continuing education activity. Please refer to the official prescribing information for each product/procedures for approved indication, contraindications, and warnings.

Copyright

Copyright © July 11, 2008 - July 11, 2009 Dane Garvin, Ltd. All Rights Reserved. Permission for accreditation use granted to The American Society for Clinical Laboratory Science.